OREXIGEN THERAPEUTICS INC Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OREXQ and buy or sell other stocks, ETFs, and their options commission-free!

About OREXQ

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. 

CEO
Michael A. Narachi, MBA
CEOMichael A. Narachi, MBA
Employees
—
Employees—
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2002
Founded2002
Employees
—
Employees—

OREXQ Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
18.01K
Average volume18.01K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.1598
52 Week high$0.1598
52 Week low
$0.001
52 Week low$0.001
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.